Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic cardiomyopathy: do women differ from men?

Jun Ren1, Asli F Ceylan-Isik

  • 1Division of Pharmaceutical Sciences and Center for Cardiovascular Research and Alternative Medicine, University of Wyoming, Laramie, WY 82071, USA. jren@uwyo.edu

Endocrine
|February 16, 2005
PubMed
Summary

Diabetic cardiomyopathy presents unique challenges for women, negating their typical cardiovascular advantage. Understanding gender differences in heart function under diabetes is crucial for effective treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beneficial impact of cardiac heavy metal scavenger metallothionein in sepsis-provoked cardiac anomalies dependent upon regulation of endoplasmic reticulum stress and ferroptosis but not autophagy.

Life sciences·2023
Same author

Retraction notice to "Endoplasmic reticulum chaperon tauroursodeoxycholic acid alleviates obesity-induced myocardial contractile dysfunction" [Journal of Molecular and Cellular Cardiology 50 (2011) 107-116].

Journal of molecular and cellular cardiology·2023
Same author

Retraction Note to: Cardiomyocyte-specific deletion of endothelin receptor A rescues aging-associated cardiac hypertrophy and contractile dysfunction: role of autophagy.

Basic research in cardiology·2022
Same author

Erratum to "Cardiac overexpression of metallothionein rescues cardiac contractile dysfunction and endoplasmic reticulum stress but not autophagy in sepsis"[J. Mol. Cell Cardiol. 48 (2010) 367-378].

Journal of molecular and cellular cardiology·2016
Same author

Ablation of Akt2 protects against lipopolysaccharide-induced cardiac dysfunction: role of Akt ubiquitination E3 ligase TRAF6.

Journal of molecular and cellular cardiology·2014
Same author

Apelin administration ameliorates high fat diet-induced cardiac hypertrophy and contractile dysfunction.

Journal of molecular and cellular cardiology·2013

Area of Science:

  • Cardiology
  • Endocrinology
  • Diabetology

Background:

  • Cardiovascular disease (CVD) risk differs between sexes, with premenopausal women generally having lower risk than men.
  • This protective
  • female advantage
  • diminishes significantly in the presence of diabetes mellitus.
  • Diabetic cardiomyopathy affects diabetic women more severely than diabetic men.

Purpose of the Study:

  • To review gender-related differences in diabetic cardiomyopathy.
  • To explore potential mechanisms contributing to these disparities, including sex hormones, intrinsic myocardial function, and metabolic pathways.

Main Methods:

  • Review of existing experimental and clinical studies focusing on gender differences in diabetic heart complications.

Related Experiment Videos

  • Analysis of factors such as sex hormones (e.g., estrogen), myocardial and endothelial function, polyol pathway metabolism, and advanced glycation endproduct formation.
  • Main Results:

    • Diabetic cardiomyopathy exhibits significant gender disparities, with higher prevalence and severity in women compared to men.
    • While female hearts may tolerate some stressors better, estrogen may interact with diabetes-related risk factors, compromising cardiac function.
    • Estrogen replacement therapy's role in diabetic cardiovascular health remains controversial.

    Conclusions:

    • Gender significantly influences the development and progression of diabetic cardiomyopathy.
    • Differences in sex hormones and intrinsic cardiac regulatory mechanisms contribute to disparities in diabetic heart complications between men and women.
    • Further research is needed to elucidate these mechanisms and develop sex-specific therapeutic strategies.